Maleic Acid

Maleic Acid

SCHEMBL8812791

O=C(O)/C=C\C(=O)O.O=C1OCc2nc(N3CCNCC3)ncc21

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol

The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTOR known ✓ P42345 1/20 0.37
▸ HSD17B10 Q99714 11/20 0.43
▸ CYP3A4 P08684 10/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 13/20 0.40
▸ CYP1A2 P05177 11/20 0.40
▸ CASP1 P29466 9/20 0.40
▸ CASP7 P55210 9/20 0.40
▸ USP2 O75604 7/20 0.40
▸ HPGD P15428 6/20 0.40
▸ HIF1A Q16665 5/20 0.40
▸ GLA P06280 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ CYP2C19 P33261 5/20 0.38
▸ CYP2C9 P11712 4/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ LMNA P02545 3/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ PMP22 Q01453 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL8812798 1.00 HSD17B10 (0.43) HSD17B10CYP3A4KDM4EALDH1A1CYP1A2
SCHEMBL8809371 0.90 ALDH1A1 (0.44) HSD17B10CYP3A4KDM4EALDH1A1CYP1A2
Maleic Acid SCHEMBL2874748 0.78 HSD17B10 (0.41) HSD17B10CYP3A4KDM4EALDH1A1CYP1A2
Maleic Acid SCHEMBL16341994 0.73 ALDH1A1 (0.39) HSD17B10CYP3A4KDM4EALDH1A1CYP1A2
2-Piperazin-1-Yl-Pyrimidine SCHEMBL10880395 0.72 KDM4E (0.68) HSD17B10CYP3A4KDM4EALDH1A1HPGD
2-Piperazin-1-Yl-Pyrimidine SCHEMBL10877794 0.72 KDM4E (0.68) HSD17B10CYP3A4KDM4EALDH1A1HPGD
SCHEMBL8810512 0.71 ALDH1A1 (0.51) HSD17B10CYP3A4KDM4EALDH1A1CYP1A2
SCHEMBL8808001 0.71 HTT (0.67) HSD17B10KDM4EALDH1A1CASP1USP2
Hydrochloric Acid SCHEMBL8809861 0.70 ALDH1A1 (0.50) HSD17B10CYP3A4KDM4EALDH1A1CYP1A2
Maleic Acid SCHEMBL2880482 0.69 HSD17B10 (0.41) HSD17B10CYP3A4KDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0257102-B1 AGENTS FOR TREATING NEUROPHATHY MITSUI PETROCHEMICAL IND (JP) 1997-11-19 — — EP disclosed
EP-0799617-A2 Therapeutic agent for neurological diseases MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1997-10-08 — — EP disclosed
US-4959368-A PYRIMIDINE DERIVATIVES MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) 1990-09-25 — — US disclosed
EP-0257102-A1 AGENTS FOR TREATING NEUROPHATHY Mitsui Chemicals, Inc. (JP) 1988-03-02 — — EP disclosed
Send feedback